{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:00:05Z","timestamp":1792123205154,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2884-0","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T01:48:43Z","timestamp":1541468923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4156-6989","authenticated-orcid":false,"given":"Jonathan A.","family":"Cook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Julious","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa V.","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse A.","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Emsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C. F.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Maclennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Stallard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne C.","family":"Rothwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke D.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"key":"2884_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","volume":"134","author":"D Altman","year":"2001","unstructured":"Altman D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663\u201394.","journal-title":"Ann Intern Med"},{"key":"2884_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3310\/hta18280","volume":"18","author":"J Cook","year":"2014","unstructured":"Cook J, et al. Assessing methods to specify the targeted difference for a randomised controlled trial - DELTA (Difference ELicitation in TriAls) review. Health Technol Assess. 2014;18:28.","journal-title":"Health Technol Assess"},{"issue":"5","key":"2884_CR3","doi-asserted-by":"publisher","first-page":"e1001645","DOI":"10.1371\/journal.pmed.1001645","volume":"11","author":"J Hislop","year":"2014","unstructured":"Hislop J, et al. Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review. PLoS Med. 2014;11(5):e1001645.","journal-title":"PLoS Med"},{"issue":"3","key":"2884_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/1740774514521907","volume":"11","author":"JA Cook","year":"2014","unstructured":"Cook JA, et al. Use of methods for specifying the target difference in randomised controlled trial sample size calculations: Two surveys of trialists' practice. Clin Trials. 2014;11(3):300\u20138.","journal-title":"Clin Trials"},{"key":"2884_CR5","doi-asserted-by":"crossref","unstructured":"Cook JA, et al. Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - DELTA2 guidance for researchers and funder representatives. Available from: \n                    https:\/\/www.csm.ox.ac.uk\/research\/methodology-research\/delta2\/delta2-output\n                    \n                  . Accessed 18 Oct 2018.","DOI":"10.1186\/s13063-018-2884-0"},{"key":"2884_CR6","unstructured":"Sones W. et al., Choosing the target difference (\u201ceffect size\u201d) for a randomised controlled trial \u2013 the development of the DELTA2 guidance Trials. 2018;19:542."},{"issue":"7211","key":"2884_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","volume":"319","author":"S Hollis","year":"1999","unstructured":"Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319(7211):670\u20134.","journal-title":"BMJ"},{"issue":"1","key":"2884_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/pst.1745","volume":"16","author":"A Phillips","year":"2017","unstructured":"Phillips A, et al. Estimands: discussion points from the PSI estimands and sensitivity expert group. Pharm Stat. 2017;16(1):6\u201311.","journal-title":"Pharm Stat"},{"issue":"1","key":"2884_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/pst.1792","volume":"16","author":"G Rosenkranz","year":"2017","unstructured":"Rosenkranz G. Estimands-new statistical principle or the emperor's new clothes? Pharm Stat. 2017;16(1):4\u20135.","journal-title":"Pharm Stat"},{"key":"2884_CR10","unstructured":"Committee for Human Medicinal Products, ICH E9 (R1) addendum on estimands and Sensitivity Analysis in Clinical Trials to the guideline on statistical principles for clinical trials EMA\/CHMP\/ICH\/436221\/2017. 2017. p. 1\u201323. Available from \n                    https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/draft-ich-e9-r1-addendum-estimands-sensitivity-analysis-clinical-trials-guideline-statistical_en.pdf\n                    \n                  . Accessed 18 Oct 2018."},{"issue":"1","key":"2884_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/sim.7033","volume":"36","author":"M Akacha","year":"2017","unstructured":"Akacha M, Bretz F, Ruberg S. Estimands in clinical trials - broadening the perspective. Stat Med. 2017;36(1):5\u201319.","journal-title":"Stat Med"},{"key":"2884_CR12","unstructured":"National Institute for Health Research. Involve. Available from: \n                    http:\/\/www.invo.org.uk\/\n                    \n                  . Accessed 18 Oct 2018."},{"issue":"9","key":"2884_CR13","first-page":"1197","volume":"165","author":"KB Chan","year":"2001","unstructured":"Chan KB, et al. How well is the clinical importance of study results reported? An assessment of randomized controlled trials. CMAJ. 2001;165(9):1197\u2013202.","journal-title":"CMAJ"},{"issue":"9467","key":"2884_CR14","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(05)61034-3","volume":"365","author":"KF Schulz","year":"2005","unstructured":"Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet. 2005;365(9467):1348\u201353.","journal-title":"Lancet"},{"issue":"24","key":"2884_CR15","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1002\/sim.2074","volume":"23","author":"S Senn","year":"2004","unstructured":"Senn S. Controversies concerning randomization and additivity in clinical trials. Stat Med. 2004;23(24):3729\u201353.","journal-title":"Stat Med"},{"key":"2884_CR16","volume-title":"Bayesian Approaches to Clinical Trials and Health-Care Evaluation","author":"DJ Spiegelhalter","year":"2004","unstructured":"Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. 1st ed. Chicester: John Wiley & Sons; 2004.","edition":"1"},{"issue":"3","key":"2884_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-121-3-199408010-00008","volume":"121","author":"SN Goodman","year":"1994","unstructured":"Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med. 1994;121(3):200\u20136.","journal-title":"Ann Intern Med"},{"key":"2884_CR18","doi-asserted-by":"publisher","first-page":"b3985","DOI":"10.1136\/bmj.b3985","volume":"339","author":"JM Bland","year":"2009","unstructured":"Bland JM. The tyranny of power: is there a better way to calculate sample size? BMJ. 2009;339:b3985.","journal-title":"BMJ"},{"issue":"4","key":"2884_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/bimj.201500228","volume":"59","author":"N Stallard","year":"2016","unstructured":"Stallard N, et al. Determination of the optimal sample size for a clinical trial accounting for the population size. Biom J. 2016;59(4):609\u201325.","journal-title":"Biom J"},{"issue":"6","key":"2884_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1191\/0962280203sm345oa","volume":"12","author":"H Pezeshk","year":"2003","unstructured":"Pezeshk H. Bayesian techniques for sample size determination in clinical trials: a short review. Stat Methods Med Res. 2003;12(6):489\u2013504.","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"2884_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0167-6296(98)00039-3","volume":"18","author":"K Claxton","year":"1999","unstructured":"Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18(3):341\u201364.","journal-title":"J Health Econ"},{"key":"2884_CR22","doi-asserted-by":"publisher","first-page":"b1732","DOI":"10.1136\/bmj.b1732","volume":"338","author":"P Charles","year":"2009","unstructured":"Charles P, et al. Reporting of sample size calculation in randomised controlled trials: review. BMJ. 2009;338:b1732.","journal-title":"BMJ"},{"key":"2884_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/9780470686164.ch3","volume-title":"Sample sizes for clinical trials","author":"S Julious","year":"2010","unstructured":"Julious S. Sample sizes for clinical trials. Boca Raton: Chapman and Hall\/CRC Press; 2010."},{"key":"2884_CR24","doi-asserted-by":"publisher","first-page":"d2786","DOI":"10.1136\/bmj.d2786","volume":"342","author":"C Hellum","year":"2011","unstructured":"Hellum C, et al. Surgery with disc prosthesis versus rehabilitation in patients with low back pain and degenerative disc: two year follow-up of randomised study. BMJ. 2011;342:d2786.","journal-title":"BMJ"},{"issue":"9768","key":"2884_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0140-6736(11)60096-2","volume":"377","author":"PD White","year":"2011","unstructured":"White PD, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. 2011;377(9768):823\u201336.","journal-title":"Lancet"},{"key":"2884_CR26","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","volume":"19","author":"S Chinn","year":"2000","unstructured":"Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med. 2000;19:3127\u201331.","journal-title":"Stat Med"},{"key":"2884_CR27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.spinee.2007.01.008","volume":"7","author":"A Copay","year":"2007","unstructured":"Copay A, et al. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 2007;7:541\u20136.","journal-title":"Spine J"},{"key":"2884_CR28","first-page":"406","volume":"28","author":"G Wells","year":"2001","unstructured":"Wells G, et al. Minimal clinically important differences: Review of methods. J Rheumatol. 2001;28:406\u201312.","journal-title":"J Rheumatol"},{"key":"2884_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00002281-200203000-00006","volume":"14","author":"D Beaton","year":"2002","unstructured":"Beaton D, Boers M, Wells G. Many faces of the minimal clinically important difference (MICD): A literature review and directions for future research. Curr Opin Rheumatol. 2002;14:109\u201314.","journal-title":"Curr Opin Rheumatol"},{"key":"2884_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1054\/bjoc.1999.0902","volume":"82","author":"P Fayers","year":"2000","unstructured":"Fayers P, et al. Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer. 2000;82:213\u20139.","journal-title":"Br J Cancer"},{"key":"2884_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13063-014-0526-8","volume":"16","author":"J Cook","year":"2015","unstructured":"Cook J, et al. Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers. Trials. 2015;16:12.","journal-title":"Trials"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2884-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2884-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2884-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T19:07:28Z","timestamp":1572894448000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2884-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2884"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2884-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,5]]},"assertion":[{"value":"20 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for the Delphi study which is part of the DELTA<sup>2<\/sup> project was sought and received from the University of Oxford\u2019s Medical Sciences Inter-divisional Research Ethics Committee (IDREC - R46815\/RE001). Informed consent was obtained for all participants in the Delphi study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was not required as no individual person data are reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed the Unified Competing Interest form at  (available on request from the corresponding author). JAB is employee of Johnson & Johnson and holds shares in this company. LVH is an employee of Novartis. The authors declare grant funding from the MRC and NIHR UK for this work. All of the other authors have been involved in design and conducting randomised trials through their roles. The authors declare that they have no other financial relationships that might have an interest in the submitted work; and all authors declare they have no other non-financial interests that may be relevant to the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"606"}}